The recent entry of an activist investor draws attention to the potential for Bio-Rad's shares to be re-rated. Read more on ...
In a repeat move, the U.S. FDA issued yet again a complete response letter (CRL) to Camurus AB for its subcutaneous extended-release injection drug CAM-2029 (octreotide) to treat the rare chronic ...
Global radiology leader Harrison.ai today launched Harrison.Rad 1.5, a radiology foundation model that can reason over images and clinical context, including priors, to produce a high-quality draft ...
Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...
NASA's Perseverance rover on Mars has collected its 24th sample of Jezero Crater. The 'Comet Geyser' sample is "great for biosignature studies," according to the space agency's Jet Propulsion ...
America’s 250 th anniversary this summer may be a bittersweet celebration, but Christina Aguilera, Will Smith, DJ Jazzy Jeff, the Roots, Jill Scott, Seal, State Property, Kathy Sledge, Infinity Song ...
May 17 (Reuters) - Activist investor Elliott Investment Management has built a sizeable stake in U.S. diagnostics supplier Bio-Rad Laboratories (BIO.N), opens new tab, and plans ‌to push the company ...
Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories to boost the firm’s underperforming stock price, the Wall Street Journal reported, citing people ...
Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
OPEC sought to project a united front Sunday, agreeing to a symbolic increase in oil output just days after the bombshell departure of the United Arab Emirates. But the pledge masks fault lines that ...
Amortization of purchased intangible assets: we do not acquire businesses and assets on a predictable cycle. The amount of purchase price allocated to purchased intangible assets and the terms of ...